Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HUBS

Go back to Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates

Moderna (MRNA) Tops Q2 EPS by 42c

August 5, 2021 6:30 AM EDT

Moderna (NASDAQ: MRNA) reported Q2 EPS of $6.46, $0.42 better than the analyst estimate of $6.04. Revenue for the quarter came in at $4.35 billion versus the consensus estimate of $4.28 billion.

Moderna COVID-19 Vaccine mRNA-1273: Final blinded analysis of Phase 3 COVE study shows 93% efficacy; Efficacy... More